Trial Profile
Oseltamivir Treatment in Children Under One Year of Age With Moderate or Severe Influenza Lower Respiratory Tract Infection - a Clinical and Pharmacokinetic Study.
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase II
Latest Information Update: 02 Sep 2015
Price :
$35
*
At a glance
- Drugs Oseltamivir (Primary)
- Indications Influenza A virus H1N1 subtype; Influenza A virus H5N1 subtype; Influenza virus infections; Respiratory tract infections
- Focus Therapeutic Use
- 26 Jul 2013 Status changed from not yet recruiting to withdrawn prior to enrolment as reported by ClinicalTrials.gov.
- 26 Jul 2013 Status changed from not yet recruiting to withdrawn prior to enrolment as reported by ClinicalTrials.gov.
- 17 Oct 2012 Planned End Date changed from 1 Jun 2014 to 1 Dec 2014 as reported by ClinicalTrials.gov (NCT01546935).